CL King Starts PetMed Express (PETS) at Strong Buy
More News related to PETS
- Rosetta Stone Inc.'s Tom Adams Named Ernst & Young Entrepreneur of the Year(R) 2009 Overall National Winner
- PetMed Express D/B/A 1-800-PetMeds Announces Its Quarterly Dividend
- Wedbush Maintains a 'Neutral' on PetMed Express (PETS); Lowers Price Target
- Unusual 11 Mid-Day Movers 10/19: FIGI, IPCS, BEST, AMPL Higher; FNM, FRE, IDCC, PETS Lower
- PetMed (PETS) Shares Trade Lower This Morning on Lower Revenue
More News related to New Coverage
- Boenning & Scattergood Downgrades NutriSystem (NTRI) to Neutral
- Raymond James Upgrades Newpark Resources (NR) to Outperform
- Raymond James Upgrades Culp (CFI) to Strong Buy
- Satyam (SAY) Jumps 5% as JPMorgan Issues Intraday Upgrade
- Credit Suisse Upgrades MDC Holdings (MDC) to Neutral, $29 Target
CL King initiates coverage on PetMed Express (Nasdaq: PETS) with a Strong Buy rating.
PetMed Express, Inc., doing business as 1-800-PetMeds, engages in the marketing and sale of prescription and non-prescription pet medications, and other health products for dogs, cats, and horses.
Related Categories
New CoverageStocks Mentioned
+0.31Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
